Common Variants in the Adiponectin Gene (ADIPOQ) Associated With Plasma Adiponectin Levels, Type 2 Diabetes, and Diabetes-Related Quantitative Traits The Framingham Offspring Study

被引:128
|
作者
Hivert, Marie-France [1 ,2 ]
Manning, Alisa K. [3 ]
McAteer, Jarred B. [4 ,5 ]
Florez, Jose C. [2 ,4 ,5 ]
Dupuis, Josee [3 ]
Fox, Caroline S. [6 ,7 ]
O'Donnell, Christopher J. [2 ,7 ]
Cupples, L. Adrienne [3 ]
Meigs, James B. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02215 USA
[4] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res & Diabet Unit, Boston, MA 02114 USA
[5] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA
[6] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
[7] NHLBI, Framingham Heart Study, Framingham, MA USA
基金
美国国家卫生研究院;
关键词
D O I
10.2337/db08-0700
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-Variants in ADIPOQ have been inconsistently associated with adiponectin levels or diabetes. Using comprehensive linkage disequilibrium mapping, we genotyped single nucleotide polymorphisms (SNPs) in ADIPOQ to evaluate the association of common variants with adiponectin levels and risk of diabetes. RESEARCH DESIGN AND METHODS-Participants in the Framingham Offspring Study (n = 2,543, 53% women) were measured for glycemic phenotypes and incident diabetes over 28 years of follow-up; adiponectin levels were quantified at exam 7. We genotyped 22 tag SNPs that captured common (minor allele frequency >0.05) variation at r(2) > 0.8 across ADIPOQ plus 20 kb 5' and 10 kb 3' of the gene. We used linear mixed effects models to test additive associations of each SNP with adiponectin levels and glycemic phenotypes. Hazard ratios (HRs) for incident diabetes were estimated using an adjusted Cox proportional hazards model. RESULTS-Two promoter SNPs in strong linkage disequilibrium with each other (r(2) = 0.80) were associated with adiponectin levels (rs17300539; P-nominal [P-n] 2.6 x 10(-8); P-empiric [P-e] = 0.0005 and rs822387; P-n = 3.8 x 10(-5); P-e = 0.001). A 3'-untranslated region (3'UTR) SNP (rs6773957) was associated with adiponectin levels (P-n = 4.4 x 10(-4); P-e = 0.005). A nonsynonymous coding SNP (rs17366743, Y111H) was confirmed to be associated with diabetes incidence (HR 1.94 [95% CI 1.16-3.25] for the minor C allele; P-n = 0.01) and with higher mean fasting glucose over 28 years of follow-up (P-n = 0.0004; P-e = 0.004). No other significant associations were found with other adiposity and metabolic phenotypes. CONCLUSIONS-Adiponectin levels are associated with SNPs in two different regulatory regions (5' promoter and 3'UTR), whereas diabetes incidence and time-averaged fasting glucose are associated with a missense SNP of ADIPOQ. Diabetes 57: 3353-3359, 2008
引用
收藏
页码:3353 / 3359
页数:7
相关论文
共 50 条
  • [21] Plasma Omentin Levels Are Inversely Associated with Atherosclerosis in Type 2 Diabetes Patients with Elevated Plasma Adiponectin Levels
    Hatamori, Masami
    Morioka, Tomoaki
    Senda, Mariko
    Kakutani, Yoshinori
    Yamazaki, Yuko
    Mori, Katsuhito
    Fukumoto, Shinya
    Shioi, Atsushi
    Shoji, Tetsuo
    Emoto, Masanori
    Inaba, Masaaki
    DIABETES, 2019, 68
  • [22] Variants of the Adiponectin Gene and Diabetic Microvascular Complications in Patients with Type 2 Diabetes
    Choe, Eun Yeong
    Wang, Hye Jin
    Kwon, Obin
    Kim, Kwang Joon
    Kim, Bum Seok
    Lee, Byung-Wan
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Kang, Eun Seok
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (05): : 677 - 685
  • [23] The role of adiponectin gene variants in glycemic control in patients with Type 2 diabetes
    Al-Azzam, Sayer I.
    Khabour, Omar F.
    Alzoubi, Karem H.
    Mukattash, Tareq L.
    Ghanma, Mais
    Saleh, Hanan
    ENDOCRINE RESEARCH, 2014, 39 (01) : 13 - 17
  • [24] Adiponectin receptor 1 gene, plasma adiponectin, and coronary heart disease in women with type 2 diabetes
    Qi, Lu
    Zhang, Cuilin
    van Dam, Rob M.
    Hu, Frank B.
    CIRCULATION, 2007, 115 (08) : E297 - E298
  • [25] Plasma adiponectin levels are associated with insulin sensitivity improved by exercise training in type 2 diabetes
    Ishii, T
    Yamakita, T
    Yamagami, K
    Fukumoto, M
    Yoshioka, K
    Hosoi, M
    Sato, T
    Tanaka, S
    Fujii, S
    DIABETES, 2002, 51 : A248 - A248
  • [26] Serum Adiponectin and Insulin Levels in Asymptomatic Offspring's of patients with Type 2 Diabetes
    Anwar, Muhammad Jawad
    Jamil, Rabiya
    Rashid, Nasir
    Rashid, Yahya
    Farooq, Muhammad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (04): : 1251 - 1252
  • [27] Association of adiponectin gene polymorphisms and their haplotypes with type 2 diabetes and related metabolic traits in an Iranian population
    Joshaghani, Hamid Reza
    Kokhaei, Parviz
    Barati, Mehdi
    Pakdel, Abbas
    Mohammadzadeh, Ghorban
    Bandegi, Navid
    Bandegi, Ahmad Reza
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2020, 40 (02) : 216 - 222
  • [28] Association of adiponectin gene polymorphisms and their haplotypes with type 2 diabetes and related metabolic traits in an Iranian population
    Hamid Reza Joshaghani
    Parviz Kokhaei
    Mehdi Barati
    Abbas Pakdel
    Ghorban Mohammadzadeh
    Navid Bandegi
    Ahmad Reza Bandegi
    International Journal of Diabetes in Developing Countries, 2020, 40 : 216 - 222
  • [29] Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes
    Chung, Hsin-Fang
    Long, Kurt Z.
    Hsu, Chih-Cheng
    Al Mamun, Abdullah
    Chiu, Yen-Feng
    Tu, Hung-Pin
    Chen, Pao-Shan
    Jhang, Huei-Ru
    Hwang, Shang-Jyh
    Huang, Meng-Chuan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 105 (02) : 261 - 270
  • [30] Plasma adiponectin levels and the development of type 2 diabetes in Japanese-Brazilians
    Vendramini, M
    Ferreira, S
    Gimeno, S
    Kasamatsu, T
    Miranda, W
    Moises, R
    DIABETES, 2003, 52 : A333 - A333